Suchergebnisse

Children exposed to caregivers with alcohol abuse disorder (AUD) are often subjected to a psychologically destabilising home environment. These caregivers may demonstrate behaviours that compromise their children's sense of safety and security and lead to a range of trauma-related symptoms. A trauma-focused treatment approach may assist with the reduction of children's trauma-related symptoms as well as the prevention of, for example, post-traumatic stress disorder (PTSD), depression, behavioural problems, and pathological shame. In this article, the authors discuss the incorporation of tenets of cognitive behavioural play therapy into a trauma-focused cognitive behavioural therapy (TF-CBT) approach for children affected by a caregiver with AUD. Additionally, the authors discuss the effects of caregiver AUD on children and outline an integrative play-based treatment approach for treating the trauma these children experience. A case example is presented to illustrate the integration of TF-CBT and cognitive behavioural play therapy (CBPT) for children with caregivers with AUD.

Intrafamilial trauma (the physical, emotional, and sexual abuse between two or more family members) can render psychologically deleterious effects not only on abused children, but their non-abused sibling(s) as well (Vitale, Squires, Zuckerbraun & Berger 2010). However, non-abused siblings are rarely the participants of trauma treatment or the focus of research, rendering them the 'forgotten survivors' of childhood maltreatment (Renner 2012; Tavkar & Hansen 2011). Nevertheless, therapists may encounter these siblings as patients as they too present myriad problematic symptoms and grief-related experiences (McMackin, Newman, Fogler & Keane 2012; Van der Kolk 2014). To assist therapists when counselling non-abused children affected by intrafamilial maltreatment, this article aims to describe the psychosocial impact of intrafamilial childhood trauma on non-abused siblings and to discuss the ways that play-based treatment can be incorporated into an empirically supported trauma treatment approach to meet their needs and grief-based concerns adequately.

Adolescence (from the ages of 10 to 19 years) is a critical stage of human development during which children experience rapid social, physical, psychological, and emotional changes on the path from childhood to adulthood. The decisions that are made during this period of life affect not only the individual well-being of young people, but also the well-being of the entire society. The Adolescent Girls Multilevel Vulnerability Index (AGI) was developed based on a growing recognition of the need to channel resources to vital—yet highly vulnerable and vastly underserved—populations of adolescent girls in Uganda specifically, and the East and Southern Africa region in general. AGI aims to be a summary indicator that can serve as an advocacy tool to draw attention to adolescent girls, a rigorous measure to inform decisions about policymaking and macro-level resource allocation, and an instrument for planning and monitoring progress. The report is a joint collaboration between the Government of Uganda, UNICEF, and the Population Council.

Advances in high-throughput genomic technologies coupled with a growing number of genomic results potentially useful in clinical care have led to ground-breaking genomic medicine implementation programs in various nations. Many of these innovative programs capitalize on unique local capabilities arising from the structure of their health care systems or their cultural or political milieu, as well as from unusual burdens of disease or risk alleles. Many such programs are being conducted in relative isolation and might benefit from sharing of approaches and lessons learned in other nations. The National Human Genome Research Institute recently brought together 25 of these groups from around the world to describe and compare projects, examine the current state of implementation and desired near-term capabilities, and identify opportunities for collaboration to promote the responsible implementation of genomic medicine.

Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising from local health care systems, cultural or political milieus, and unusual selected risk alleles or disease burdens. Such individual eforts might beneft from the sharing of approaches and lessons learned in other locales. The U.S. National Human Genome Research Institute and the National Academy of Medicine recently brought together 25 of these groups to compare projects, to examine the current state of implementation and desired near-term capabilities, and to identify opportunities for collaboration that promote the responsible practice of genomic medicine. Eforts to coalesce these groups around concrete but compelling signature projects should accelerate the responsible implementation of genomic medicine in eforts to improve clinical care worldwide.